Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
about
Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancerCyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesisExtracellular matrix associated protein CYR61 is linked to prostate cancer developmentInvolvement of Cyr61 in growth, migration, and metastasis of prostate cancer cellsSilencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanomaTargeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer TherapyThe effect of superparamagnetic iron oxide with iRGD peptide on the labeling of pancreatic cancer cells in vitro: a preliminary study.The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy.Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers.Cyr61 expression is associated with prognosis in patients with colorectal cancer.Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment.Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparinsCCN1 Induces β-Catenin Translocation in Esophageal Squamous Cell Carcinoma through Integrin α11.Prognostic significance of expression of cysteine-rich 61 and cyclooxygenase-2 in gastric cancer.Overexpression of periostin predicts poor prognosis in non-small cell lung cancer.Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.Cyr61 is a potential prognostic marker for prostate cancer.Applications of microarray technology to pancreatic cancer research and drug development.Human pancreatic cancer progression: an anarchy among CCN-siblings.The up-regulation of cysteine-rich protein 61 induced by transforming growth factor beta enhances osteosarcoma cell migration.The matricellular protein CCN1 suppresses lung cancer cell growth by inducing senescence via the p53/p21 pathway.Differential Effects of MicroRNAs on Glioblastoma Growth and Migration.CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer.The matrix protein CCN1/CYR61 is required for α(V)β5-mediated cancer cell migration.Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness.Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.Tumor-derived intercellular adhesion molecule-1 mediates tumor-associated leukocyte infiltration in orthotopic pancreatic xenografts.CCN1: a novel target for pancreatic cancer.Regulation of CCN1 via the 3'-untranslated region.Knockdown of cysteine-rich 61 inhibits proliferation, migration, and invasiveness of prostate carcinoma PC-3 cells
P2860
Q21144447-06C7AE5D-38B2-4A27-8143-15417C5B22ECQ21245763-4836EC4A-D53E-43D2-B83B-256D22B1ABE3Q24623715-09D5C04A-64CC-4C7C-A621-1D0EC6096F43Q24655999-64AE8AC2-3345-44D4-87B4-7439FE84E09AQ24656407-A199515B-897D-466D-B9E7-77C9A27F2203Q28078129-5E11459B-E073-42B9-8D85-730ACC266C5CQ33746572-94908EE2-B16E-457B-902A-0D26521DFE62Q34067767-BC663D5B-26E0-4E82-80EE-E7241BAB4D51Q34165809-C0568718-6EE1-4DD6-A312-2F91C8A13570Q34348691-34263D2B-2117-4BE5-B14F-61A4D37E61B0Q35113999-37D77C18-B078-4C63-8E6F-1FCECE182844Q35176786-51C10FD2-F0BA-4EB9-8ED3-DF33B8032AD4Q35810537-C54C636C-379B-4C5F-9A84-3B6519EDEDA1Q36020686-D9FCB5DC-EDAA-4E0F-A03F-F4233CBB6AE4Q36085411-53B5C495-5CC6-47C7-9D78-B389A8FF47C3Q37328529-DE72B282-9B28-4C5D-8947-CA385CD896FDQ37447362-36382C09-74C7-4F9B-B05F-DBC163DD9B17Q37985500-9D51222E-5AB1-4523-9E55-C8A0DE284683Q38089806-78C73702-3D8D-4689-89EB-6E47BD236D8EQ38931858-E54B7546-9A55-4A31-A995-88A3781FAA8AQ39095924-E9F4F539-11DC-4190-84A5-4BB436F3AEEAQ39171928-854DD635-5CB3-4285-A83C-041548F951A5Q39219681-077ADF11-E04B-4B77-AE2A-82FDE48E5CEEQ39321392-47FEA2FF-E1DE-40F7-8018-6959128A1929Q39332268-30369062-AE46-4C0F-8C29-E95C1CC201A8Q39453245-39392DC9-902C-4E65-8E98-72CA80174848Q39580020-B21804FC-0C78-4BF5-B22E-2200F75D8C39Q39713136-53FC6734-60C6-4213-84F1-4425895A5937Q41807028-632B477B-580C-442C-80CC-80C443673F02Q43095749-79A5C4C8-1E0F-4DF8-B9D5-EEC49EDF006CQ58139757-D54BB08C-CB5D-4040-AB01-E45CDFC47B23
P2860
Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Increased expression of Cyr61 ...... from human pancreatic cancer.
@en
type
label
Increased expression of Cyr61 ...... from human pancreatic cancer.
@en
prefLabel
Increased expression of Cyr61 ...... from human pancreatic cancer.
@en
P2093
P1476
Increased expression of Cyr61 ...... from human pancreatic cancer.
@en
P2093
Carlton C Barnett
Jason B Fleming
Luc Girard
M Raffat Jaber
Rolf A Brekken
Shane E Holloway
P304
P356
10.1016/J.JAMCOLLSURG.2004.10.005
P50
P577
2005-03-01T00:00:00Z